Clinical Trial Update: Effectiveness and Safety of Xiaoshuanchangrong (XSCR) Capsule for the Treatment of Patients Who Have Suffered From a Stroke [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update assesses the effectiveness and safety of Xiaoshuanchangrong (XSCR) Capsule for acute ischemic stroke in Phase 2 and Phase 3, sponsore…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Xiaoshuanchangrong Capsule

Snippet

Sponsor: Fudan University | Conditions: Acute Ischemic Stroke | Phase 2, Phase 3 | Status: UNKNOWN